Doxycycline Hydrochloride Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition
Doxycycline Hydrochloride Price Trend, Index and Forecast
Track the latest insights on doxycycline hydrochloride price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Europe, Middle East, Africa, and Asia Pacific.
Doxycycline Hydrochloride Prices Outlook Q2 2026
- USA: USD 53908/MT
- China: USD 47265/MT
- Germany: USD 53247/MT
- India: USD 52237/MT
- Brazil: USD 55046/MT
Doxycycline Hydrochloride Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the second quarter of 2026, the doxycycline hydrochloride prices in the USA reached 53908 USD/MT in June. Prices rose as strong demand from the healthcare sector and increased raw material costs supported market activity. The antibiotic market sustained consumption of doxycycline hydrochloride, maintaining its significant importance. Higher logistics costs further encouraged elevated pricing levels.
During the second quarter of 2026, the doxycycline hydrochloride prices in China reached 47265 USD/MT in June. Prices increased due to higher production costs and global demand recovery, directly impacting the market dynamics. Active procurement for use in pharmaceutical applications further pushed pricing upwards significantly. Increasing raw material and energy costs contributed to the overall rise.
During the second quarter of 2026, the doxycycline hydrochloride prices in Germany reached 53247 USD/MT in June. Prices moved upward as tighter delivered supply and stronger export enquiries supported the European market. Logistics disruptions and delayed deliveries limited the timely movement of material, increasing supply chain concerns. Demand from medicinal three and human health applications sustained market activity.
During the second quarter of 2026, the doxycycline hydrochloride prices in India reached 52237 USD/MT in June. Prices increased as heightened domestic and export demand drove procurement amid rising input costs. The unfinished supply chain constraints further bolstered price escalation, amplifying production challenges. Strong demand from pharmaceutical manufacturing sectors coupled with increased logistics costs provided firm support.
During the second quarter of 2026, the doxycycline hydrochloride prices in Brazil reached 55046 USD/MT in June. The demand from local health sectors and increased import costs contributed to the rising price trend. Increases in international shipping expenses and currency fluctuations also provided pricing momentum. Active market participation by healthcare product manufacturers supported stable consumption levels.
Doxycycline Hydrochloride Prices Outlook Q4 2025
- USA: USD 50023/MT
- China: USD 44905/MT
- Germany: USD 50632/MT
- India: USD 49624/MT
- Brazil: USD 50830/MT
During the fourth quarter of 2025, the doxycycline hydrochloride prices in the USA reached 50023 USD/MT in December. Prices increased, supported by steady demand from antibiotic formulation manufacturers and hospital procurement programs. Additionally, structured sourcing of active pharmaceutical ingredients and consistent domestic distribution activity influenced supply positioning across pharmaceutical supply chains.
During the fourth quarter of 2025, the doxycycline hydrochloride prices in China reached 44905 USD/MT in December. Prices rose, driven by firm export demand and active domestic antibiotic production. Moreover, balanced fermentation-based API output and stable raw material supply shaped manufacturing economics across key pharmaceutical clusters.
During the fourth quarter of 2025, the doxycycline hydrochloride prices in Germany reached 50632 USD/MT in December. Prices moved upward, influenced by sustained demand from generic drug manufacturers and healthcare procurement networks. Furthermore, regulated pharmaceutical compliance standards and structured import positioning shaped regional availability.
During the fourth quarter of 2025, the doxycycline hydrochloride prices in India reached 49624 USD/MT in December. Prices increased, supported by active API manufacturing and export-oriented pharmaceutical production. In addition to this, stable input availability and coordinated production scheduling influenced supply dynamics across major industrial hubs.
During the fourth quarter of 2025, the doxycycline hydrochloride prices in Brazil reached 50830 USD/MT in December. Prices rose, driven by steady demand from domestic antibiotic formulators and public healthcare supply programs. Apart from this, import positioning and distributor-level inventory planning shaped procurement cycles.
Doxycycline Hydrochloride Prices Outlook Q3 2025
- USA: USD 49090/MT
- China: USD 43977/MT
- Germany: USD 49693/MT
- India: USD 48225/MT
- Brazil: USD 49135/MT
During the third quarter of 2025, the doxycycline hydrochloride prices in the USA reached 49090 USD/MT in September. Prices moved upward as demand from pharmaceutical formulation units and hospital supply channels increased. Higher procurement for antibiotic formulations and regulated healthcare markets supported buying activity. Buyers aligned sourcing with production schedules and regulatory documentation requirements, while steady API availability influenced purchasing strategies.
During the third quarter of 2025, the doxycycline hydrochloride prices in China reached 43977 USD/MT in September. Prices increased due to steady export demand and sustained domestic consumption from API manufacturers. Improved order visibility from overseas buyers supported procurement activity. Buyers coordinated sourcing with manufacturing schedules, supported by sufficient domestic production capacity.
During the third quarter of 2025, the doxycycline hydrochloride prices in Germany reached 49693 USD/MT in September. Prices declined as demand from pharmaceutical distributors and formulation units softened. Inventory drawdowns and cautious procurement behavior influenced sourcing decisions. Buyers focused on meeting immediate formulation needs while managing compliance and batch documentation requirements.
During the third quarter of 2025, the doxycycline hydrochloride prices in India reached 48225 USD/MT in September. Prices moved upward due to strong demand from export-oriented pharmaceutical manufacturers and domestic formulation units. Increased supplies to regulated and semi-regulated markets supported consumption. Buyers aligned procurement with production planning and regulatory timelines.
During the third quarter of 2025, the doxycycline hydrochloride prices in Brazil reached 49135 USD/MT in September. Prices declined amid reduced public healthcare procurement and cautious distributor purchasing. Adequate import availability influenced sourcing behavior. Buyers limited purchases to near-term operational requirements and tender-based demand.
Doxycycline Hydrochloride Prices Outlook Q2 2025
- USA: USD 48270/MT
- China: USD 43370/MT
- Germany: USD 50348/MT
- India: USD 47140/MT
- Brazil: USD 51023/MT
During the second quarter of 2025, the doxycycline hydrochloride prices in the USA reached 48270 USD/MT in June. Demand from pharmaceutical formulation units and healthcare supply chains influenced procurement activity. Buyers aligned sourcing with production schedules and inventory planning.
During the second quarter of 2025, the doxycycline hydrochloride prices in China reached 43370 USD/MT in June. Consumption from export-oriented API manufacturing shaped procurement patterns. Domestic production capacity and inventory availability supported material access.
During the second quarter of 2025, the doxycycline hydrochloride prices in Germany reached 50348 USD/MT in June. Demand from pharmaceutical distributors and formulation units guided sourcing decisions. Buyers coordinated procurement with regulatory compliance and batch documentation requirements.
During the second quarter of 2025, the doxycycline hydrochloride prices in India reached 47140 USD/MT in June. Procurement was influenced by export demand and domestic formulation requirements. Buyers structured sourcing around confirmed manufacturing schedules.
During the second quarter of 2025, the doxycycline hydrochloride prices in Brazil reached 51023 USD/MT in June. Demand from public healthcare tenders and pharmaceutical distributors shaped procurement volumes. Import availability and logistics considerations influenced sourcing timelines.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast, and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices and the key factors influencing doxycycline hydrochloride prices.
Europe Doxycycline Hydrochloride Price Trend
Q2 2026:
The doxycycline hydrochloride price index in Europe moved upward as limited supply availability, steady pharmaceutical demand, and rising logistics expenses supported firmer market conditions. Pharmaceutical manufacturers and healthcare suppliers maintained consistent procurement due to ongoing requirements for antibiotic formulations, keeping demand levels stable throughout the quarter. Supply chain disruptions affected delivery schedules and created challenges in maintaining regular inventory replenishment. Geopolitical uncertainties in Eastern Europe further influenced trade flows and increased concerns regarding supply continuity. Port delays, customs clearance issues, and changing regulatory requirements added complexity to regional distribution networks.
Q4 2025:
As per the doxycycline hydrochloride price index, European prices moved upward, supported by consistent demand from generic drug manufacturers and hospital procurement networks across Western Europe. Additionally, regulated pharmaceutical production standards and reliance on imported active pharmaceutical ingredients influenced regional supply positioning. Procurement activity remained aligned with confirmed antibiotic formulation schedules, while structured distribution through established pharmaceutical hubs shaped pricing dynamics across the region.
Q3 2025:
Europe experienced downward price movement, led by declining prices in Germany. Softer demand from pharmaceutical distributors and formulation units influenced regional procurement behavior. Buyers relied on existing inventories and long-term supply contracts, reducing spot market activity. Regulatory compliance requirements, batch certification, and documentation timelines continued to shape sourcing decisions. Import availability supported supply continuity, with procurement volumes aligned closely to confirmed formulation schedules rather than forward inventory accumulation.
Q2 2025:
In Europe, doxycycline hydrochloride demand was shaped by routine pharmaceutical formulation activity and distributor-led sourcing across regulated healthcare markets. Buyers coordinated procurement with production planning, quality assurance protocols, and regulatory documentation requirements. Import availability and established logistics networks supported material access. Purchasing strategies emphasized specification compliance, traceability, and uninterrupted supply for hospital and retail pharmaceutical channels.
This analysis can be extended to include detailed doxycycline hydrochloride price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Doxycycline Hydrochloride Price Trend
Q2 2026:
The doxycycline hydrochloride price index in North America increased as limited inventory levels, strong healthcare demand, and supply chain pressures supported higher market quotations. Pharmaceutical companies continued regular procurement to support antibiotic production and healthcare requirements, maintaining steady consumption across the region. Restricted availability and production challenges reduced supply flexibility, encouraging buyers to secure material in advance. Higher transportation expenses, border delays, and distribution challenges added further pressure on delivered costs for pharmaceutical manufacturers and suppliers. Export demand from international markets also influenced regional availability by absorbing part of the available supply. Producers managed inventories cautiously as they balanced domestic requirements with external commitments.
Q4 2025:
As per the doxycycline hydrochloride price index, prices in North America increased, driven by steady antibiotic consumption across hospital systems and retail pharmacy supply chains. Furthermore, structured API sourcing strategies and stable domestic distribution infrastructure maintained balanced availability. Buyers aligned procurement volumes with confirmed pharmaceutical manufacturing throughput, reinforcing the upward pricing direction.
Q3 2025:
North America experienced upward price movement, driven by increases in the USA. Improved demand from hospital procurement programs and pharmaceutical formulation units supported consumption. Buyers advanced sourcing to meet prescription demand and inventory requirements. Domestic distribution networks and import availability supported supply continuity, while procurement decisions remained aligned with confirmed healthcare demand rather than speculative stocking.
Q2 2025:
In North America, doxycycline hydrochloride demand reflected procurement aligned with pharmaceutical formulation schedules and hospital supply planning. Buyers coordinated sourcing with inventory management, regulatory compliance, and batch release timelines. Import flows and established supplier relationships supported material availability, while procurement strategies focused on maintaining continuity for regulated manufacturing and healthcare distribution.
Specific doxycycline hydrochloride historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Doxycycline Hydrochloride Price Trend
Q2 2026:
The study includes doxycycline hydrochloride price trends across the Middle East and Africa, considering essential factors that have a direct impact on market prices, such as regional industrial growth, healthcare expansion, and political stability. Geopolitical tensions and evolving trade routes generally influenced price fluctuations.
Q4 2025:
As per doxycycline hydrochloride price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
Q3 2025:
The report explores the doxycycline hydrochloride pricing trends and doxycycline hydrochloride price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on doxycycline hydrochloride prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Doxycycline Hydrochloride Price Trend
Q2 2026:
The doxycycline hydrochloride price trend across Asia Pacific moved upward as strong pharmaceutical demand, rising production expenses, and tighter supply conditions supported higher market quotations. Demand from antibiotic manufacturers and healthcare providers remained steady as doxycycline hydrochloride continued to be widely used in pharmaceutical formulations. Major regional producers faced increasing pressure from higher raw material costs, manufacturing expenses, and compliance requirements, which influenced supplier pricing strategies. Supply availability was affected by production adjustments and cautious inventory management among manufacturers, limiting immediate spot availability for buyers. Export demand from international markets also contributed to tighter regional supply conditions as Asian suppliers balanced domestic requirements with overseas commitments.
Q4 2025:
Across Asia Pacific, doxycycline hydrochloride prices rose, supported by active API production and sustained export demand from key manufacturing economies. Additionally, fermentation-based production integration and stable raw material availability influenced output levels. Buyers across pharmaceutical clusters maintained procurement aligned with confirmed antibiotic formulation demand, shaping regional pricing behavior.
Q3 2025:
Asia Pacific experienced upward price movement, supported by increases in China and India. Strong demand from export-oriented pharmaceutical manufacturers and domestic formulation units drove regional consumption. Buyers adjusted sourcing strategies based on export order visibility and regulatory destination requirements. Domestic production capacity and regional trade flows supported material availability across key manufacturing hubs.
Q2 2025:
In Asia Pacific, doxycycline hydrochloride demand was shaped by pharmaceutical formulation activity across China and India. Buyers coordinated procurement with production planning, export order schedules, and compliance documentation requirements. Domestic supply availability and regional trade supported continuity, while procurement strategies emphasized operational alignment and batch traceability.
This doxycycline hydrochloride price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Doxycycline Hydrochloride Price Trend
Q2 2026:
The doxycycline hydrochloride price trend across Latin America moved upward as steady pharmaceutical demand, import dependency, and rising supply chain expenses supported firmer market conditions. Healthcare providers and pharmaceutical manufacturers maintained consistent procurement activity due to the continued requirement for antibiotic formulations. Limited regional production capacity increased reliance on imported supplies, making prices more sensitive to international availability, freight conditions, and supplier pricing strategies. Higher transportation expenses and longer delivery routes added pressure on procurement costs for distributors and pharmaceutical companies.
Q4 2025:
Regional market assessments across Latin America indicated an upward pricing trend for doxycycline hydrochloride, supported by steady public healthcare procurement and private-sector antibiotic manufacturing. Additionally, reliance on imported API volumes and coordinated distributor inventory management influenced supply positioning across major pharmaceutical markets in the region.
Q3 2025:
Latin America experienced downward price movement, led by declining prices in Brazil. Reduced public healthcare procurement and cautious distributor purchasing softened regional consumption. Buyers limited sourcing volumes amid inventory optimization efforts. Import availability supported supply, allowing procurement to remain closely aligned with confirmed formulation and tender-based requirements.
Q2 2025:
In Latin America, doxycycline hydrochloride procurement reflected demand from pharmaceutical distributors and formulation units supplying public and private healthcare channels. Buyers scheduled sourcing based on confirmed supply commitments and tender cycles. Import flows and logistics coordination supported material availability, while procurement strategies focused on ensuring continuity of supply.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Doxycycline Hydrochloride Pricing Report, Market Analysis, and News
IMARC's latest publication, “Doxycycline Hydrochloride Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” provides an in-depth analysis of the doxycycline hydrochloride market dynamics. This report examines spot price variations at major ports and explores price compositions, including FOB and CIF terms. Detailed doxycycline hydrochloride price trend analysis by region highlights global shifts across North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting doxycycline hydrochloride pricing, such as supply-demand dynamics, geopolitical influences, and sector-specific developments, are rigorously evaluated. This comprehensive report equips stakeholders with the latest market news, regulatory updates, and technological advancements, aiding in informed strategic decision-making and forecasting.
Doxycycline Hydrochloride Industry Analysis
The global doxycycline hydrochloride market size reached 89.6 Thousand Tonnes in 2025. By 2034, IMARC Group anticipates the market will grow to 131.2 Thousand Tonnes, at a projected CAGR of 4.33% during 2026-2034. The market growth is primarily propelled by increasing demand for antibiotic formulations, rising awareness in emerging markets, and advancements in drug delivery systems.
Latest News and Developments:
- June 2025: Alembic Pharmaceuticals Limited announced that it received final approval from the United States Food and Drug Administration (US FDA) for its Doxorubicin Hydrochloride Liposome Injection in strengths of 20 mg/10 mL and 50 mg/25 mL. The product is indicated for the treatment of ovarian cancer, AIDS-related Kaposi’s sarcoma, and multiple myeloma, and is manufactured at the company’s oncology formulation facility in India.
- June 2025: A study by scientists published on BioRxiv investigated doxycycline hydrochloride release from a collagen hydrogel containing entrapped γ-cyclodextrin oligomers to improve controlled drug delivery. The research found that incorporating these cyclodextrin oligomers enhanced the amount of doxycycline hydrochloride that could be released by approximately 220% and slowed its release rate significantly compared to conventional formulations.
Product Description
Doxycycline hydrochloride is a derivative of tetracycline antibiotics used widely for treating bacterial infections in the respiratory, urinary, and reproductive systems. It is synthesized through the controlled acidification and crystallization of doxycycline, ensuring high purity and stability. Besides human therapeutic applications, it is employed in veterinary practice to manage infections in animals. Its strong bioavailability, effectiveness against a wide range of bacteria, and affordable synthesis make it a preferred choice in medical and veterinary scenarios. Doxycycline hydrochloride is further characterized by its minimal side effects and versatility in different formulations, contributing to its sustained demand globally.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Doxycycline Hydrochloride |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Doxycycline Hydrochloride Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of doxycycline hydrochloride pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting doxycycline hydrochloride price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The doxycycline hydrochloride price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
Related Reports
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.